T38622 |
Bcl-xL antagonist 2
|
|
BCL
|
|
Bcl-xL antagonist 2 is an effective and selective antagonist of Bcl-xL with an IC50 of 91 nM and a Ki of 65 nM. Bcl-xL a... |
T77571 |
Bcl-B inhibitor 1
|
|
Apoptosis
,
BCL
|
|
Bcl-B inhibitor 1 is a Bcl-B inhibitor with antitumor activity that binds to and inactivates pro-apoptotic proteins in t... |
T39961 |
Bcl-2-IN-2
|
|
|
|
Bcl-2-IN-2 is a highly potent and selective inhibitor targeting Bcl-2 and Bcl-xL. It displays an IC50 value of 0.034 nM,... |
T10483 |
Lisaftoclax
|
APG-2575,Bcl-2/Bcl-xl inhibitor 1 |
BCL
|
|
Lisaftoclax is an oral dual inhibitor of Bcl-2 and Bcl-xl, with IC50 values of 2 nM and 5.9 nM for Bcl-2 and Bcl-xl, res... |
T74298 |
Bcl-2-IN-5
|
|
|
|
Bcl-2-IN-5 is a BCL-2 inhibitor with IC 50 s of 0.12 nM, 0.14 nM and 0.22 nM for Bcl-2 wild type, Bcl-2 D103Y and Bcl-2 ... |
T74297 |
Bcl-2-IN-4
|
|
|
|
Bcl-2-IN-4 is a potent, orally active and selective Bcl-2 inhibitor with an IC 50 of 1.5 nM. Bcl-2-IN-4 displays >200-fo... |
T63757 |
Bcl-2-IN-9
|
|
|
|
Bcl-2-IN-9 is a novel, pro-apoptotic, low cytotoxic Bcl-2 inhibitor (IC50: 2.9 μM). Bcl-2-IN-9 downregulates Bcl-2 expre... |
T64053 |
Bcl-2-IN-8
|
|
|
|
Bcl-2-IN-8 is a potent anti-cancer agent. bcl-2-IN-8 exhibits anti-proliferative effects on both drug-sensitive and drug... |
T63676 |
Bcl-2-IN-6
|
|
|
|
Bcl-2-IN-6 is a potent inhibitor of Bcl-2 (b-cell lymphoma-2) that downregulates Bcl-2 expression and increases the expr... |
T63521 |
Bcl-2-IN-7
|
|
|
|
Bcl-2-IN-7 is a potent inhibitor of Bcl-2 (b-cell lymphoma-2), which can downregulate the expression of Bcl-2, increase ... |
T11968 |
MCL-1/BCL-2-IN-1
|
|
BCL
|
|
MCL-1/BCL-2-IN-2 (Compound Nap-1) is a potent and selective dual inhibitor of Mcl-1 and Bcl-2 with IC 50 s of 4.45 and 3... |
T11971 |
MCL-1/BCL-2-IN-4
|
|
Others
|
|
MCL-1/BCL-2-IN-4 is a selective and potent Mcl-1 and Bcl-2 dual inhibitor. |
T11969 |
MCL-1/BCL-2-IN-2
|
|
Others
|
|
MCL-1/BCL-2-IN-2 is a potent and selective Bcl-2 and Mcl-1 dual inhibitor. |
T11970 |
MCL-1/BCL-2-IN-3
|
|
Others
|
|
MCL-1/BCL-2-IN-3 is a selective and potent Mcl-1 and Bcl-2 dual inhibitor with IC50s of 5.95 and 4.78 μM, respectiely. |
T74138 |
PROTAC Bcl-xL degrader-2
|
|
|
|
PROTAC Bcl-xL degrader-2 is a potent Bcl-xL ( Bcl-2 family member) degrader based on von Hippel-Lindau ligand, with an I... |
T73957 |
PROTAC Bcl-xL degrader-1
|
|
|
|
PROTAC Bcl-xL degrader-1 is a PROTAC that comprises a Bcl-xL ( Bcl-2 family member) ligand binding group, a linker and a... |
T74137 |
PROTAC Bcl-xL ligand-1
|
|
|
|
PROTAC Bcl-xL ligand-1 is a ligand for Bcl-xL that can be used in the synthesis of PROTACs [1] . |
T73999 |
PROTAC Bcl-xL degrader-3
|
|
|
|
PROTAC Bcl-xL degrader-3 is a potent ROTAC Bcl-xL degrader (WO2020163823A2, compound 44) [1] . |
T62249 |
Bcl-2/Mcl-1-IN-1
|
|
|
|
Bcl-2/Mcl-1-IN-1 is an inhibitor of Bcl-2 (Ki: 4.53 μM) and Mcl-1 (Ki: 1.19 μM).Bcl-2/Mcl-1-IN-1 can be used in cancer r... |
T62941 |
Bcl-2/Mcl-1-IN-3
|
|
|
|
Bcl-2/Mcl-1-IN-3 is a Bcl-2/Mcl-1 inhibitor that acts on Mcl-1 (Ki: 0.14 μM) and Bcl-2 (Ki: 0.23 μM) and can be used in ... |